NAVIDEA BIOPHARMACEUTICALS, INC. Current Liabilities
NAVIDEA BIOPHARMACEUTICALS, INC. had Current Liabilities of $7.98 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2023-11-14
- 2023-09-30: Liabilities, Current $7.98M.
- 2023-06-30: Liabilities, Current $8.31M.
- 2023-03-31: Liabilities, Current $9.25M.
- 2022-12-31: Liabilities, Current $9.94M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2023-09-30 | $7.98M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.31M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $9.25M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $9.94M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $8.43M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.32M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $4.90M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $5.30M 10-K · filed 2023-03-27 | |
| 2021-09-30 | $4.10M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $4.02M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $4.16M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $4.72M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $4.01M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $4.15M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $4.35M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $3.82M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.58M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.82M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.42M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.38M 10-K · filed 2020-03-18 | |
| 2018-09-30 | $5.85M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $4.63M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $12.03M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $8.07M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $5.88M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $7.89M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $9.98M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $69.86M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $63.76M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $62.39M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $57.09M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $6.18M 8-K · filed 2017-12-15 | |
| 2015-09-30 | $6.24M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.59M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $12.90M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $9.06M 10-K · filed 2016-03-23 | $9.10M 10-K · filed 2015-03-16 |
| 2014-09-30 | $8.33M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $6.15M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $5.45M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $11.29M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $6.31M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $4.72M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $5.83M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $6.19M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $7.01M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $5.60M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $4.92M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $3.35M 10-K/A · filed 2013-03-21 | |
| 2011-09-30 | $4.18M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $4.99M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $3.94M 10-K · filed 2012-03-07 |